Cargando…

Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform

Genetic polymorphisms of enzymes and transporters associated with the absorption, distribution, metabolism, and elimination (ADME) of drugs are one of the major factors that contribute to interindividual variations in drug response. In the present study, we aimed to elucidate the pharmacogenetic pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Byungwook, Yoon, Deok Yong, Lee, SeungHwan, Jang, In-Jin, Yu, Kyung-Sang, Cho, Joo-Youn, Oh, Jaeseong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492395/ https://www.ncbi.nlm.nih.gov/pubmed/34621706 http://dx.doi.org/10.12793/tcp.2021.29.e14

Ejemplares similares

DMET-Analyzer: automatic analysis of Affymetrix DMET Data
por: Guzzi, Pietro Hiram, et al.
Publicado: (2012)

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease
por: Jin, Xuanyou, et al.
Publicado: (2020)

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine
por: Arbitrio, Mariamena, et al.
Publicado: (2016)

Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP(®)) Biosimilar, to Those of NESP(®) After a Single Subcutaneous or Intravenous Administration to Healthy Subjects
por: Jeon, Inseung, et al.
Publicado: (2021)

Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects
por: Jiang, Xu, et al.
Publicado: (2023)

Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans
por: Han, Nayoung, et al.
Publicado: (2021)

The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans
por: Oh, Jaeseong, et al.
Publicado: (2017)

Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers
por: Chung, Woo Kyung, et al.
Publicado: (2022)

Comprehensive characterization of pharmacogenes in a Taiwanese Han population
por: Lu, Hsing-Fang, et al.
Publicado: (2022)

The Affymetrix DMET Plus Platform Reveals Unique Distribution of ADME-Related Variants in Ethnic Arabs
por: Wakil, Salma M., et al.
Publicado: (2015)

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study
por: Na, Joo Young, et al.
Publicado: (2022)

Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase
por: Kang, Jihyun, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
por: Rhee, Su-jin, et al.
Publicado: (2016)

A Machine Learning-Based Identification of Genes Affecting the Pharmacokinetics of Tacrolimus Using the DMET(TM) Plus Platform
por: Gim, Jeong-An, et al.
Publicado: (2020)

Genetic diversity of ‘Very Important Pharmacogenes’ in two South-Asian populations
por: Bharti, Neeraj, et al.
Publicado: (2021)

Evaluation of the effects of food on levodropropizine controlled-release tablet and its pharmacokinetic profile in comparison to that of immediate-release tablet
por: Lee, Soyoung, et al.
Publicado: (2018)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

A Parallel Software Pipeline for DMET Microarray Genotyping Data Analysis
por: Agapito, Giuseppe, et al.
Publicado: (2018)

DMET(TM) Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine
por: Agapito, Giuseppe, et al.
Publicado: (2020)

Clinical Evaluation of Digital Therapeutics: Present and Future
por: Huh, Ki Young, et al.
Publicado: (2022)

Effects of rifampin coadministration on the pharmacokinetics of digoxin: a real-world data approach
por: Oh, JungJin, et al.
Publicado: (2023)

Single‐dose of LC51‐0255, a selective S1P(1) receptor modulator, showed dose‐dependent and reversible reduction of absolute lymphocyte count in humans
por: Won Lee, Sang, et al.
Publicado: (2022)

Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects
por: Hwang, Inyoung, et al.
Publicado: (2022)

Chemical curation to improve data accuracy: recent development of the 3DMET database
por: Maeda, Miki H., et al.
Publicado: (2018)

iDMET: network-based approach for integrating differential analysis of cancer metabolomics
por: Matsuta, Rira, et al.
Publicado: (2022)

Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects
por: Jung, Jihyun, et al.
Publicado: (2021)

Comprehensive Allele Genotyping in Critical Pharmacogenes Reduces Residual Clinical Risk in Diverse Populations
por: Luo, Shishi, et al.
Publicado: (2021)

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease
por: Powell, Nicholas R., et al.
Publicado: (2023)

The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects
por: Hwang, Sejung, et al.
Publicado: (2022)

Retraction and Republication: A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies
por: Chung, Inbum, et al.
Publicado: (2018)

A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies
por: Chung, Inbum, et al.
Publicado: (2018)

A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies
por: Chung, Inbum, et al.
Publicado: (2017)

Pharmacogene regulatory elements: from discovery to applications
por: Smith, Robin P, et al.
Publicado: (2012)

Identification, conservation, and expression of tiered pharmacogenes in zebrafish
por: Demery-Poulos, Catherine, et al.
Publicado: (2022)

Genetic Variation among Pharmacogenes in the Sardinian Population
por: Idda, Maria Laura, et al.
Publicado: (2022)

Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China
por: Wang, Yuliang, et al.
Publicado: (2021)

Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials
por: Kim, Seokuee, et al.
Publicado: (2017)

Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences
por: Lee, Seung‐been, et al.
Publicado: (2019)

Genotyping Performance between Saliva and Blood-Derived Genomic DNAs on the DMET Array: A Comparison
por: Hu, Yueshan, et al.
Publicado: (2012)

Ontogeny-related pharmacogene changes in the pediatric liver transcriptome
por: Meier, Richard, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tedom0ft23jugskmd2svqis53h